trial · primary record
18F-fluciclovine injection
Multiple Myeloma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2032-12-06 |
| Primary endpoint | To determine the concordance between 18F-fluciclovine PET/CT and 18F-FDG PET/CT in participants with multiple myeloma. |
| Registry ID | NCT06103838 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:22.855Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06103838
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.